Mobily and Sanofi offer blood glucose measuring device

Etihad Etisalat (Mobily) and Sanofi-Avetnsi, a global health care leader, have announced the launch of Sanofi’s device (iBG star) the first blood glucose measuring device via iPhone, iPad and iPod, which is sold exclusively through Mobily’s outlets throughout the Kingdom.
Mobily claims to be the first telecommunication in the Middle East to offer in its stores this innovative device as a step in improving its (mHealth) status in Saudi Arabia, which help the patients controlling and following up on their chronic diseases on a regular bases anywhere, especially the common chronic diseases such as diabetes.
iBG star is a small, discreet device and easy to use.
It can be plugged to iPhone, iPad and iPods to measure the blood glucose level using an app (iBG star Diabetes Manager Application) to record, track and manage the patient’s information in an intuitive format.
The application is available free of charge in Apple Store.
iBGStar meets today’s stringent industry standards for accuracy and features plasma equivalent calibration for assurance with each and every reading as it uses Dynamic Electrochemistry technology.
According to Mobily there is no additional service charges as the user will only pay for the device.
“Offering the mHealth solutions goes along with the technological evolution the world is experiencing at the moment as the smart phones and tablet users are increasing tremendously, which have made these devices irreplaceable in our daily activities,” said Mobily’s CEO Khalid Alkaf.
“We are proud in Sanofi Saudi Arabia to launch (iBG star) in collaboration with Mobily. As Sanofi offers the integrated and 360 health care solutions for valuable customers, this device will help our patients to have an improved quality of life and better control of their disease,” said Salah Mousa, general manager, Sanofi Saudi Arabia.